Cystic Fibrosis Newborn Screening Webinar Series
Expert-led webinars on key topics in CF newborn screening.
The Cystic Fibrosis Newborn Screening Webinar Series, hosted by CPHI, offers expert-led presentations on important topics related to CF newborn screening.
This webinar series is part of the Cystic Fibrosis Newborn Screening Collaboratives, which are designed to support state newborn screening programs in the U.S.
UPCOMING WEBINARS
Wednesday, April 15th, 1:00 – 2:00 PM ET
Cystic Fibrosis Modulators in Pregnancy and the Impact on Newborn Screening Results
Speakers: Jennifer L. Taylor, MD, MSCS, National Jewish Health and Clement Ren, MD, MBA, Children’s Hospital of Philadelphia
The Center for Public Health Innovation, with grant support from the Cystic Fibrosis Foundation, is pleased to announce an upcoming webinar on modulator use during pregnancy and discuss approaches to ensure that all infants at risk for CF that are also exposed to modulator therapies receive timely identification and treatment.
Modulator therapy in cystic fibrosis is being used to treat individuals with cystic fibrosis who become pregnant, and in pregnancies with a fetus known or suspected to have CF. The newborn screening results may result in a normal IRT, potentially delaying the identification of some affected infants.
Email us at Info@CPHInnovation.org and ask to be put on our list to be notified about future webinars.
Visit our YouTube channel to view past webinars.
For more information on the webinar series or to join a CF NBS Collaborative, please reach out to Info@CPHInnovation.org.
These webinars are funded by the Cystic Fibrosis Foundation (SONTAG24QI0 and MCCOLL19QI0).